Can you really bootstrap a medtech company? The answer is yes.

Innovators seeking to enter the world of medtech face a daunting path from concept to commercialization. Design, engineering, prototyping and preclinical testing to prepare a single FDA regulatory submission are just a few examples of the many hurdles medtech innovators must successfully clear before event attempting to realize any revenue. For John O’Shaughnessy, Founder and…

Tearing down workforce development silos and supporting next-level collaboration for job growth

We have long maintained that the robust elements of Atlanta’s medtech ecosystem are ripe to support new, high-value job creation in Atlanta and throughout the southeastern United States. Through this lens of job creation through innovation, I was honored to be appointed for a second term on the National Advisory Council on Innovation and Entrepreneurship…

Grab insights on development paths for spine therapy innovation including preclinical testing in the $15 billion global market. Connect onsite with T3 Labs at NASS 2016.

According to Markets and Markets Research, the global market for spinal implants and devices will top $15 billion by 2020. In North America, the gathering with arguably the greatest ability to influence that market, its innovation and growth is the North American Spine Society (NASS) Annual Meeting. T3 Labs’ Orthopaedic and Spine Program Director Dr.…

Breakthroughs in preventing and treating GI disorders: what to look forward to at ACG 2016

The American College of Gastroenterology annual conference serves as the premier gastrointestinal event of the year: delivering the latest clinical updates on a wide spectrum of GI disorders. The ACG’s mission is to advance world-class care for patients with gastrointestinal disorders using innovative methods in prevention and treatment. As an industry leading preclinical CRO for…

Talking Medtech Innovation and Capital Formation at AdvaMed 2016

AdvaMed is the leading medtech industry conference in North America. From October 17-19, 2016 Minneapolis will host thousands of medtech industry leaders gathered together in a multifaceted environment for business development, capital formation, technology showcasing, world-class educational opportunities and networking. GCMI was founded upon, and still operates with, the goal of providing necessary resources and…

What it takes to bring a medical device from concept to commercialization: Webinar Oct.26

Now more than ever, physician innovators entering into the medical device ecosystem are experiencing a highly regulated and cost constrained environment. Maneuvering through this world is not for the faint of heart and takes more than sheer will: it takes a multidisciplinary team. Navigating the journey from concept to commercialization for novel new products and…

Maneuvering through a world of regulation: advice from a seasoned medtech innovator

Now more than ever, physician innovators are entering into a highly regulated and cost constrained environment. “This industry is not for the faint of heart,” says Rafael Andino, Vice President of Engineering and Manufacturing for Clearside Biomedical, Inc. Andino is part of a team of innovators that built a biopharmaceutical company from concept to clinical…

From concept to commercialization: how GCMI is helping one physician innovator bring new medtech out of his garage and into a $10B market

GCMI is a multifunctional tool. This is made apparent by stories like Hunter Moyer’s with Vivid LED technologies. Before finding and engaging GCMI he had already conceptualized a new medtech product, built a prototype, and then found himself asking “What’s next?” That is where GCMI stepped in. The desire to better existing technologies for facial…